Importantly, the recipient mice transplanted with Cyclin D2-overexpressed CD274-null AML cells developed AML much faster than the CD274-null AML counterparts, which was comparable to the case in the WT controls (Fig. 3e, f). This evidence concerns the gene CCND2 and acute myeloid leukemia.